The lack of long-range negative correlations in glucose dynamics is associated with worse glucose control in patients with diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 61, Issue 7, 2012, Pages 1041-1050

  Ogata, Hitomi ^a,b   Tokuyama, Kumpei ^c   Nagasaka, Shoichiro ^d   Tsuchita, Takeshi ^d   Kusaka, Ikuyo ^d   Ishibashi, Shun ^d   Suzuki, Hiroaki ^c   Yamada, Nobuhiro ^c   Hamano, Kumiko ^e   Kiyono, Ken ^f   Struzik, Zbigniew R ^a   Yamamoto, Yoshiharu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

^f NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 ANHYDROSORBITOL; ALPHA GLUCOSIDASE INHIBITOR; BIPHASIC INSULIN; C PEPTIDE; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; INSULIN; LONG ACTING INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; SHORT ACTING INSULIN; SULFONYLUREA;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETES MELLITUS; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; JAPANESE; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; DEOXYGLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; SERUM ALBUMIN;

EID: 84863415706     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.12.007     Document Type: Article

References (36)

1. D.C. Klonoff Continuous glucose monitoring: roadmap for 21st century diabetes therapy Diabetes Care 28 2005 1231 1239 (Pubitemid 40616646)
2. C.M. McDonnell, S.M. Donath, S.I. Vidmar, G.A. Werther, and F.J. Cameron A novel approach to continuous glucose analysis utilizing glycemic variation Diabetes Technol Ther 7 2005 253 263 (Pubitemid 40586369)
3. W. Clarke, and B. Kovatchev Statistical tools to analyze continuous glucose monitor data Diabetes Technol Ther 11 Suppl 1 2009 S45 54
4. H. Ogata, K. Tokuyama, S. Nagasaka, A. Ando, I. Kusaka, and N. Sato Long-range negative correlation of glucose dynamics in humans and its breakdown in diabetes mellitus Am J Physiol Regul Integr Comp Physiol 291 2006 R1638 R1643
5. C.K. Peng, S. Havlin, H.E. Stanley, and A.L. Goldberger Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series Chaos 5 1995 82 87
6. J. Churruca, L. Vigil, E. Luna, J. Ruiz-Galiana, and M. Varela The route to diabetes: loss of complexity in the glycemic profile from health through the metabolic syndrome to type 2 diabetes Diabetes Metab Syndr Obes 1 2008 3 11
7. K. Lundelin, L. Vigil, S. Bua, I. Gomez-Mestre, T. Honrubia, and M. Varela Differences in complexity of glycemic profile in survivors and nonsurvivors in an intensive care unit: a pilot study Crit Care Med 38 2010 849 854
8. S. Rahbar, O. Blumenfeld, and H.M. Ranney Studies of an unusual hemoglobin in patients with diabetes mellitus Biochem Biophys Res Commun 36 1969 838 843
9. C.E. Guthrow, M.A. Morris, J.F. Day, S.R. Thorpe, and J.W. Baynes Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus Proc Natl Acad Sci USA 76 1979 4258 4261 (Pubitemid 9256541)
10. K. Shima, N. Ito, F. Abe, M. Hirota, M. Yano, and Y. Yamamoto High-performance liquid chromatographic assay of serum glycated albumin Diabetologia 31 1988 627 631
11. T. Yamanouchi, S. Minoda, M. Yabuuchi, Y. Akanuma, H. Akanuma, and H. Miyashita Plasma 1,5-anhydro-d-glucitol as new clinical marker of glycemic control in NIDDM patients Diabetes 38 1989 723 729 (Pubitemid 19285725)
12. K.M. Dungan, J.B. Buse, J. Largay, M.M. Kelly, E.A. Button, and S. Kato 1,5-Anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes Diabetes Care 29 2006 1214 1219 (Pubitemid 44125912)
13. T. Kuzuya, T. Saito, S. Yoshida, and A. Matsuda Human C-peptide immunoreactivity (CPR) in blood and urine - evaluation of a radioimmunoassay method and its clinical applications Diabetologia 12 1976 511 518
14. A.E. Kitabchi Proinsulin and C-peptide: a review Metaboslim 26 1977 547 587
15. J. Mastrototaro The MiniMed Continuous Glucose Monitoring System (CGMS) J Pediatr Endocrinol Metab Suppl 3 1999 751 758 (Pubitemid 30002854)
16. K. Rebrin, and G.M. Steil Can interstitial glucose assessment replace blood glucose measurements? Diabetes Technol Ther 2 2000 461 472
17. T. Koschinsky, and L. Heinemann Sensors for glucose monitoring: technical and clinical aspects Diabetes Metab Res Rev 17 2001 113 123 (Pubitemid 32427959)
18. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
19. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
20. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
21. M. Tominaga, H. Makino, G. Yoshino, K. Kuwa, I. Takei, and Y. Aono Japanese standard reference material JDS Lot 2 for hemoglobin A1c. II: present state of standardization of hemoglobin A1c in Japan using the new reference material in routine clinical assays Ann Clin Biochem 42 2005 47 50 (Pubitemid 40209065)
22. H. Sone, H. Ito, Y. Ohashi, Y. Akanuma, N. Yamada Japan Diabetes Complications Study Group Obesity and type 2 diabetes in Japanese patients Lancet 361 2003 85 (Pubitemid 36050984)
23. Y. Seino, K. Nanjo, N. Tajima, T. Kadowaki, A. Kashiwagi, and E. Araki Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus J Diabetes Invest 1 2010 212 228
24. A. Matsuda, and T. Kuzuya Urine C-peptide after recovery from diabetic ketoacidosis: an index of insulin dependency Diabetes Care 5 1982 581 584 (Pubitemid 13241019)
25. A. Matsuda, and T. Kuzuya Urine C-peptide in relation to the degree of insulin dependence in diabetic patients Diabetes Res Clin Pract 1 1985 65 72 (Pubitemid 17034150)
26. F.J. Service, G.D. Molnar, J.W. Rosevear, E. Ackerman, L.C. Gatewood, and W.F. Taylor Mean amplitude of glycemic excursions, a measure of diabetic instability Diabetes 19 1970 644 655
27. H. Akaike Information theory and an extension of the maximum likelihood principle 1973 Budapest Akademiai Kiado 261 281
28. T. Yamanouchi, and Y. Akanuma Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control Diabetes Res Clin Pract 24 1994 S261 S268
29. M. Kishimoto, Y. Yamasaki, M. Kubota, K. Arai, T. Morishima, and R. Kawamori 1,5-Anhydro-d-glucitol evaluates daily glycemic excursions in well-controlled NIDDM Diabetes Care 18 1995 1156 1159
30. T. Yamanouchi, N. Ogata, T. Tagaya, T. Kawasaki, N. Sekino, and H. Funato Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycemic control Lancet 347 1996 1514 1518 (Pubitemid 26162642)
31. S.E. Siegelaar, F. Holleman, J.B. Hoekstra, and J.H. DeVries Glucose variability; does it matter? Endocr Rev 31 2010 171 182
32. A. Tura, U. Morbiducci, S. Sbrignadello, Y. Winhofer, G. Pacini, and A. Kautzky-Willer Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance Am J Physiol Regul Integr Comp Physiol 300 2011 R941 R948
33. N. Yamamoto, Y. Kubo, K. Ishizawa, G. Kim, T. Moriya, and T. Yamanouchi Detrended fluctuation analysis is considered to be useful as a new indicator for short-term glucose complexity Diabetes Technol Ther 12 2010 775 783
34. T. Kuzuya, A. Matsuda, Y. Sakamoto, S. Tanabshi, and H. Kajinuma C-peptide immunoreactivity (CPR) in urine Diabetes 27 Suppl 1 1978 210 215 (Pubitemid 8303575)
35. A. Taniguchi, Y. Nakai, M. Fukushima, H. Kawamura, H. Imura, and I. Nagata Pathogenic factors responsible for glucose intolerance in patients with NIDDM Diabetes 41 1992 1540 1546
36. H. Sakuraba, H. Mizukami, N. Yagihashi, R. Wada, C. Hanyu, and S. Yagihashi Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients Diabetologia 45 2002 85 96 (Pubitemid 34118546)